Literature DB >> 27291085

National surveillance for meningococcal disease in Japan, 1999-2014.

Munehisa Fukusumi1, Hajime Kamiya2, Hideyuki Takahashi3, Mizue Kanai4, Yushi Hachisu4, Takehito Saitoh5, Makoto Ohnishi3, Kazunori Oishi5, Tomimasa Sunagawa5.   

Abstract

We summarize the epidemiology of Japanese meningococcal disease with serogroup distribution. One hundred seventy-eight meningococcal meningitis cases were reported from April 1999 to March 2013 to the national surveillance system. From April 2013, bacteremia was added to the condition of reporting invasive meningococcal disease (IMD). Since then, 59 IMD cases were reported by the end of 2014. Approximately two thirds of the cases were male and the median age was 56years (range: 0-93years). Only 3% of the cases were <5years old. One third of reported cases were meningitis and the others were bacteremia. The annual incidence (2014) for IMD was 0.028 per 100,000 and case fatality rate (CFR) was 19%. Serogroup Y (42%) was the most dominant serogroup, followed by C (12%), B (7%) and W (3%). Even though the number of reported cases has increased after the amendment of reporting requirements, the incidence of IMD is still low in Japan. Underreporting may play a role in this low incidence. Improving on the limitations of the surveillance system is necessary to capture the true epidemiology and accurate serogroup distribution of IMD cases in Japan, which is essential for making effective recommendations on newly licensed vaccine.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Japan; Meningococcal vaccine; Neisseria meningitidis; Surveillance

Mesh:

Year:  2016        PMID: 27291085     DOI: 10.1016/j.vaccine.2016.06.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database.

Authors:  Yumi Matsumura
Journal:  Drug Healthc Patient Saf       Date:  2020-11-10

Review 2.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

3.  Prophylactic amoxicillin for the prevention of meningococcal infection in infants with atypical hemolytic uremic syndrome under treatment with eculizumab: a report of two cases.

Authors:  Kazuki Tanaka; Naoya Fujita; Satoshi Hibino
Journal:  CEN Case Rep       Date:  2020-04-02

Review 4.  A rare case of purulent meningitis caused by Capnocytophaga canimorsus in the Czech Republic - case report and review of the literature.

Authors:  Petr Prasil; Lenka Ryskova; Stanislav Plisek; Pavel Bostik
Journal:  BMC Infect Dis       Date:  2020-02-03       Impact factor: 3.090

Review 5.  Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.

Authors:  Sandra Guedes; Isabelle Bertrand-Gerentes; Keith Evans; Florence Coste; Philipp Oster
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

6.  Meningococcal disease outbreak related to the World Scout Jamboree in Japan, 2015.

Authors:  Mizue Kanai; Hajime Kamiya; Alison Smith-Palmer; Hideyuki Takahashi; Yushi Hachisu; Munehisa Fukusumi; Takehito Saitoh; Makoto Ohnishi; Tomimasa Sunagawa; Tamano Matsui; Kazunori Oishi
Journal:  Western Pac Surveill Response J       Date:  2017-05-08

7.  Epidemiology of vaccine-preventable diseases in Japan: considerations for pre-travel advice for the 2019 Rugby World Cup and 2020 Summer Olympic and Paralympic Games.

Authors:  Matthew M Griffith; Munehisa Fukusumi; Yusuke Kobayashi; Yusuke Matsui; Shingo Nishiki; Reiko Shimbashi; Saeko Morino; Tomimasa Sunagawa; Keiko Tanaka-Taya; Tamano Matsui; Kazunori Oishi
Journal:  Western Pac Surveill Response J       Date:  2018-06-30

8.  Epidemiological profile of Neisseria meningitidis in Casablanca, Morocco: 2010-2019.

Authors:  Khadija Ait Mouss; Aziza Razki; Eva Hong; Bahija Zaki; Fakhreddine Maaloum; Néhémie Nzoyikorera; Houria Belabbes; Naima Elmdaghri; Khalid Zerouali
Journal:  Access Microbiol       Date:  2020-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.